Clinical Trials Update: July 19, 2006
Cold Sores (Herpes Labialis Infections) Irritable Bowel Syndrome (IBS) Batten Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Cold Sores (Herpes Labialis Infections)
This study will determine if an investigational medication can speed cold sores healing time when compared to currently available medications.
Qualified participants must have a history of recurrent cold sores. (You do not need to have a cold sore right now to be eligible for participation.) Compensation is available for time and travel.
The research sites are in the states of Washington and Ohio, and the city of Minneapolis.
Irritable Bowel Syndrome (IBS)
If you are a woman with a history of IBS with diarrhea for at least the past 6 months and are age 18 to 65, you may qualify for a clinical research study of an investigational medication.
Symptoms of IBS include bloating, change in bowel habits, diarrhea, and abdominal pain/discomfort. Qualified participants may receive compensation up to $350 for time and travel.
The research site is located in Mogadore, Ohio.
Human Central Nervous System Stem Cells (HuCNS-SC) is an investigational product derived from human brain cells.
Participation in a study using this product will involve screening assessments, surgery to implant HuCNS-SC, medication to suppress the immune system, and a series of follow-up assessments.
Candidates between the ages of 1 and 12 who have a clinical diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) or late infantile neuronal ceroid lipofuscinosis (LINCL), a mutation of the CLN1 or CLN2 gene, and severe cognitive, communication, behavior and language impairment may qualify.
Children who have previously received an organ, tissue or bone marrow transplantation or have a bleeding disorder will not qualify.
The research site is in Portland, Ore.
Copyright 2006 Thomson CenterWatch. All rights reserved.